Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Bastiaan Driehuys
- Study ID
- NCT07139899
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hyperpolarized Xenon 129 — COMBINATION_PRODUCTPulmonary magnetic resonance imaging using hyperpolarized xenon-129 gas as an inhaled contrast agent
Study Details
In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with severe asthma. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corresponding to the airways downstream of mucus plugs.
Key Dates
- Start date
- Nov 17, 2025
- Status verified
- Nov 2025
- Primary completion
- Nov 30, 2026
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 5 participants (estimated)
Primary Outcome Measure
Ventilation Defect in Mucus-blocked regions [ Time Frame: 12 weeks ]
Central Contacts
- David Mummy, PhD9846847783
- Bastiaan Driehuys, PhD919-684-7786
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27713 | - |
Find similar trials in Durham, NC
By condition
By specialty
By research site
Related Studies
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)PHASE3 · Recruiting · Generate Biomedicines · Northridge, California
- A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe AsthmaPHASE2 · Not Yet Recruiting · Kinaset Therapeutics Inc · Lancaster, California
- Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe AsthmaRecruiting · University of Kansas Medical Center · Kansas City, Kansas
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)PHASE3 · Recruiting · Generate Biomedicines · Bakersfield, California